Beijing Succeeder Technology Inc (688338) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Beijing Succeeder Technology Inc (688338) has a cash flow conversion efficiency ratio of 0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥13.97 Million ≈ $2.04 Million USD) by net assets (CN¥1.66 Billion ≈ $243.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Beijing Succeeder Technology Inc - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Beijing Succeeder Technology Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Beijing Succeeder Technology Inc total liabilities for a breakdown of total debt and financial obligations.
Beijing Succeeder Technology Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beijing Succeeder Technology Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Abm Investama Tbk
JK:ABMM
|
0.038x |
|
NIIT LEARNING SYSTEMS LTD
NSE:NIITMTS
|
N/A |
|
Chengdu Tianjian Technology Co Ltd
SHE:002977
|
-0.045x |
|
Deutsche Rohstoff AG
XETRA:DR0
|
0.138x |
|
Waterdrop Inc ADR
NYSE:WDH
|
-0.010x |
|
Kforce Inc.
NYSE:KFRC
|
0.158x |
|
Shenzhen RoadRover Technology Co Ltd
SHE:002813
|
-0.077x |
|
Beijing AriTime Intelligent Control Co Ltd
SHG:600560
|
-0.045x |
Annual Cash Flow Conversion Efficiency for Beijing Succeeder Technology Inc (2016–2024)
The table below shows the annual cash flow conversion efficiency of Beijing Succeeder Technology Inc from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Beijing Succeeder Technology Inc (688338) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.65 Billion ≈ $240.89 Million |
CN¥122.98 Million ≈ $18.00 Million |
0.075x | +9.04% |
| 2023-12-31 | CN¥1.60 Billion ≈ $234.16 Million |
CN¥109.64 Million ≈ $16.04 Million |
0.069x | +2.52% |
| 2022-12-31 | CN¥1.50 Billion ≈ $220.16 Million |
CN¥100.56 Million ≈ $14.71 Million |
0.067x | -11.60% |
| 2021-12-31 | CN¥1.42 Billion ≈ $207.92 Million |
CN¥107.42 Million ≈ $15.72 Million |
0.076x | +41.88% |
| 2020-12-31 | CN¥1.36 Billion ≈ $198.45 Million |
CN¥72.27 Million ≈ $10.57 Million |
0.053x | -67.24% |
| 2019-12-31 | CN¥374.69 Million ≈ $54.83 Million |
CN¥60.94 Million ≈ $8.92 Million |
0.163x | -45.28% |
| 2018-12-31 | CN¥195.65 Million ≈ $28.63 Million |
CN¥58.15 Million ≈ $8.51 Million |
0.297x | +30.33% |
| 2017-12-31 | CN¥143.30 Million ≈ $20.97 Million |
CN¥32.68 Million ≈ $4.78 Million |
0.228x | -32.88% |
| 2016-12-31 | CN¥103.89 Million ≈ $15.20 Million |
CN¥35.30 Million ≈ $5.17 Million |
0.340x | -- |
About Beijing Succeeder Technology Inc
Beijing Succeeder Technology Inc. engages in the research and development, manufacture, and sale of in-vitro diagnostic products in China and internationally. The company offers coagulation testers, hemorheology testers, erythrocyte sedimentation testers, platelet aggregation testers, diagnostic reagents, quality control products. Its products are used in the prevention, screening, diagnosis, and… Read more